ACTG 5280: High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
ACTG 5277: Safety and Activity of the HCV Entry Inhibitor ITX 5061 in Mono-Infected Adults
This study is evaluating an experiemental drug, ITX 5061, being developed to treat hepatitis C virus (HCV).
ACTG 5272: Oral HPV Shedding and Oral Warts After Starting Antiretrovial Therapy
This is a study for those who have never been on anti-HIV medication before, and are planning to start it either as part of another study or by their primary care provider. The study will look at how common oral warts and the virus that causes oral warts (oral human papillomavirus or HPV) are before and after starting anti-HIV medication.
Lung Microbiome Study: Alteration in Lung Microbiome in Acute and Chronic HIV Infection
This study plans to learn more about pulmonary complications of HIV/AIDS.
IRC 001: A Pilot Study for collection of Anti-Influenza A H1N1 Immune Plasma
IRC001 is a plasma collection study that will enroll healthy volunteers who have had the flu or received the H1N1 flu vaccine and are found to have high levels of H1N1 antibodies in their blood.
IRC 003: A Randomized Double-Blind, Phase 2 Study Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications
IRC003 is a study enrolling people at risk of getting severe flu.